| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 5,115.8 | 3,754.3 |
| Profit before tax | 2,284.1 | 1,763.3 |
| Net income | 1,948.7 | 1,460.0 |
| EPS (diluted, $ a share) | $18.45 | $13.62 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +33.5% |
|---|---|
| Revenue, year on year | +36.3% |
| Operating margin | 40.0% |
10-Q filed with the SEC, NASDAQ: REGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Regeneron Pharmaceuticals, Inc.: key numbers
- Share price
- $957.76Close, Nov 17
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Regeneron Pharmaceuticals, Inc.
All →Regeneron Pharmaceuticals SVP Controller Jason Pitofsky Sells $3.83M of Stock
Jason Pitofsky, SVP Controller, sold 4,062 shares of Regeneron Pharmaceuticals, Inc. at $939.57 to $950.76 a share (average $942.19) in 8 transactions, worth $3.83M in total on Nov 4, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $3.83M
- Shares
- 4,062
- Average price
- $942.19
- Role
- SVP Controller
- Holding change
- -100.0%
- Trade date
- Nov 4, 2026
Regeneron Pharmaceuticals Insider Huda Y. Zoghbi Sells $7.22M of Stock
Huda Y. Zoghbi sold 7,439 shares of Regeneron Pharmaceuticals, Inc. at $970.42 to $971.06 a share (average $970.46) in 2 transactions, worth $7.22M in total on Nov 3, 2026. Shares held after the trade: 1,703 (-22.7%).
- Value
- $7.22M
- Shares
- 7,439
- Average price
- $970.46
- Holding change
- -22.7%
- Trade date
- Nov 3, 2026
Regeneron Pharmaceuticals Insider George L. Sing Sells $20.4M of Stock
George L. Sing sold 21,129 shares of Regeneron Pharmaceuticals, Inc. at $960.57 to $970.18 a share (average $964.38) in 9 transactions, worth $20.4M in total on Nov 2, 2026. Shares held after the trade: 25,147 (-0.8%).
- Value
- $20.4M
- Shares
- 21,129
- Average price
- $964.38
- Holding change
- -0.8%
- Trade date
- Nov 2, 2026
Regeneron Pharmaceuticals Insider Christine A. Poon Sells $7.59M of Stock
Christine A. Poon sold 7,830 shares of Regeneron Pharmaceuticals, Inc. at $966.74 to $971.31 a share (average $969.09) in 6 transactions, worth $7.59M in total on Nov 2, 2026. Shares held after the trade: 5,219 (-3.7%).
- Value
- $7.59M
- Shares
- 7,830
- Average price
- $969.09
- Holding change
- -3.7%
- Trade date
- Nov 2, 2026
Regeneron Pharmaceuticals EVP General Counsel and Secret Joseph J. Larosa Sells $4.31M of Stock
Joseph J. Larosa, EVP General Counsel and Secret, sold 4,466 shares of Regeneron Pharmaceuticals, Inc. at $965.41 to $966.11 a share (average $965.49) in 2 transactions, worth $4.31M in total on Nov 2, 2026. Shares held after the trade: 38,906 (-1.3%).
- Value
- $4.31M
- Shares
- 4,466
- Average price
- $965.49
- Role
- EVP General Counsel and Secret
- Holding change
- -1.3%
- Trade date
- Nov 2, 2026
Regeneron Pharmaceuticals Insider Kathryn Guarini Sells $360K of Stock
Kathryn Guarini sold 400 shares of Regeneron Pharmaceuticals, Inc. at $900.00 a share, worth $360K in total on Oct 30, 2026. Shares held after the trade: 603 (-39.9%).
- Value
- $360K
- Shares
- 400
- Price
- $900.00
- Holding change
- -39.9%
- Trade date
- Oct 30, 2026